Lam Research Corporation $LRCX Stock Sold by Geneva Partners LLC

Geneva Partners LLC cut its stake in Lam Research Corporation (NASDAQ:LRCX) by 21.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 11,968 shares of the semiconductor company’s stock after selling 3,315 shares during the quarter. Lam Research accounts for 1.2% of Geneva Partners LLC’s holdings, making the stock its 29th biggest position. Geneva Partners LLC’s holdings in Lam Research were worth $3,932,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also modified their holdings of the company. Paladin Partners LLC bought a new stake in shares of Lam Research in the 2nd quarter valued at $26,000. Dakota Community Bank & Trust NA acquired a new stake in Lam Research during the 3rd quarter worth $33,000. Quintet Private Bank Europe S.A. raised its stake in Lam Research by 100.0% during the 3rd quarter. Quintet Private Bank Europe S.A. now owns 100 shares of the semiconductor company’s stock worth $33,000 after buying an additional 50 shares during the period. Bravera Wealth bought a new position in Lam Research during the second quarter worth about $46,000. Finally, Cedar Mountain Advisors LLC lifted its holdings in Lam Research by 242.9% during the first quarter. Cedar Mountain Advisors LLC now owns 120 shares of the semiconductor company’s stock worth $26,000 after acquiring an additional 85 shares in the last quarter. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Lam Research Price Performance

Shares of NASDAQ LRCX opened at $237.50 on Tuesday. The firm has a market cap of $296.68 billion, a PE ratio of 34.04, a PEG ratio of 0.86 and a beta of 1.85. The company has a current ratio of 2.48, a quick ratio of 1.86 and a debt-to-equity ratio of 0.27. Lam Research Corporation has a 1-year low of $135.50 and a 1-year high of $438.50. The company has a fifty day moving average price of $302.39 and a 200 day moving average price of $282.90.

Lam Research (NASDAQ:LRCX) last released its earnings results on Wednesday, October 21st. The semiconductor company reported $2.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.18 by $0.02. Lam Research had a return on equity of 72.15% and a net margin of 32.34%. The firm had revenue of $8.22 billion during the quarter, compared to analysts’ expectations of $8.14 billion. During the same quarter in the prior year, the company earned $1.26 EPS. The company’s revenue was up 54.4% on a year-over-year basis. Research analysts predict that Lam Research Corporation will post 9.48 earnings per share for the current fiscal year.

Lam Research Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, October 14th. Stockholders of record on Wednesday, September 23rd were given a dividend of $0.33 per share. This is an increase from Lam Research’s previous quarterly dividend of $0.26. This represents a $1.32 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend was Wednesday, September 23rd. Lam Research’s payout ratio is currently 19.67%.

Insider Activity

In related news, insider Ava Harter sold 5,000 shares of the stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $302.46, for a total transaction of $1,512,300.00. Following the completion of the transaction, the insider directly owned 42,462 shares in the company, valued at approximately $12,843,056.52. This trade represents a 10.53% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Bethany Mayer sold 9,557 shares of Lam Research stock in a transaction that occurred on Wednesday, September 9th. The shares were sold at an average price of $314.74, for a total value of $3,007,970.18. Following the completion of the sale, the director directly owned 20,995 shares in the company, valued at approximately $6,607,966.30. This represents a 31.28% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.31% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the company. Berenberg Bank set a $420.00 target price on Lam Research in a research note on Wednesday, September 9th. Cantor Fitzgerald set a $500.00 price target on Lam Research and gave the stock an “overweight” rating in a research report on Monday, June 29th. Fundamental Research set a $390.00 price objective on Lam Research in a report on Thursday, October 1st. Weiss Ratings lowered Lam Research from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, September 4th. Finally, Stifel Nicolaus boosted their price objective on Lam Research from $325.00 to $425.00 and gave the company a “buy” rating in a research report on Friday, July 10th. Twenty-six investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $360.23.

Lam Research News Summary

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Lam Research stock gained despite a Citi price-target cut, suggesting investor confidence in the company’s fundamentals and AI-related demand outweighed the more cautious valuation view. Lam Research Stocks Gain 4.3% Despite Citi’s Target Cut
• Positive Sentiment: An analyst upgraded Lam Research, arguing that the stock’s decline has improved its risk-reward profile and that the underlying financial outlook has strengthened. Lam Research: Down 29% Since My Sell Call, But The Math Has Changed
• Positive Sentiment: An analyst raised the company’s fiscal 2027 EPS forecast, reinforcing expectations for continued earnings growth. FY2027 EPS Forecast for Lam Research Raised by Analyst
• Positive Sentiment: Long-term investment analyses remain bullish, citing strong cash flow, semiconductor demand and exposure to artificial-intelligence infrastructure as potential drivers of further upside. Lam Research vs. AMAT and KLAC Why Lam Research Is a Top Growth Stock
• Neutral Sentiment: A roundup of analyst actions involving LRCX indicates changing Wall Street views, but the specific recommendations and targets were mixed. Analyst Upgrades and Downgrades
• Neutral Sentiment: Reported short interest totaled zero shares, implying no measurable short-selling pressure; however, the unusual figure may reflect a reporting or data issue rather than a meaningful market signal.
• Negative Sentiment: Citi’s lower price target highlights valuation and near-term uncertainty, creating a potential headwind even though the broader market reaction was positive. Analysts Offer Insights on Lam Research
• Negative Sentiment: Recent weakness across AI and chip stocks, along with concerns about supply constraints and sharp sector corrections, shows that LRCX remains exposed to elevated semiconductor volatility. Chip Stocks to Buy After Their Worst Day Since June

Lam Research Profile

Lam Research Corporation (NASDAQ:LRCX) is a semiconductor equipment company that develops and manufactures systems used to fabricate integrated circuits. Its technologies support key stages of wafer processing, helping semiconductor manufacturers create the increasingly complex structures found in memory, logic and other types of chips.

The company’s product portfolio includes etch systems, which selectively remove materials from wafers; deposition systems, which apply thin films; and cleaning solutions used to remove contaminants and residue during manufacturing.